NCT01216943 - Safety and Efficacy of Triple Combination Therapy in Patients With Glaucoma or Ocular Hypertension | Biotech Hunter

Enrollment

126

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions

GlaucomaOcular Hypertension

Interventions

DRUG

bimatoprost/brimonidine tartrate/timolol fixed combination ophthalmic solution

One drop of Triple Combination Therapy (bimatoprost/brimonidine tartrate/timolol fixed combination ophthalmic solution) administered to each eye, twice daily for 12 weeks.

Trial Locations (1)

Unknown

Coimbatore